Patents/Assignees

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

8 patents in portfolio

US12599604utility2026
Application of JAK Inhibitor in Kidney Disease
0 cites
US12590081utility2026
Fused Imidazole Derivatives, Preparation Method and Medicinal Use Thereof
0 cites
US12492166utility2025
Sulfonylurea Derivative and Medical Uses Thereof
0 cites
US12473279utility2025
Fused Imidazole Derivative, Preparation Method Therefor, and Medical Use Thereof
0 cites
US12459937utility2025
Fused Imidazole Derivative, Preparation Method Therefor, and Medical Use Thereof
0 cites
US12227499utility2025
Fused Imidazole Derivative, Preparation Method Therefor, and Medical Use Thereof
0 cites
US12215103utility2025
Fused Imidazole Derivative, Preparation Method Therefor, and Medical Use Thereof
0 cites
US11801252utility2023
Pharmaceutical Composition
0 cites